[DOI] [PubMed] [Google Scholar] Ramos Catharino R., de Azevedo Marques L., Silva Santos L., Baptista A
Alternative Therapies in Health and Medicine, 13(2), S154-S156
Cardiovascular Disease or Uncontrolled Hypertension - There is insufficient research on the safety of PT-141, oxytocin, or tadalafil during pregnancy or lactation
Tosi, M
The product will be marketed under the brand name Noveltreat, providing a more affordable alternative once the original patent expires
Use: Short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification, and caloric restriction in the management of exogenous obesity in patients with an initial body mass index (BMI) of 30 kg/m2 or greater, or BMI of 27 kg/m2 or greater in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia)